Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Jun 16:2019:9171424.
doi: 10.1155/2019/9171424. eCollection 2019.

Theories of Aging and the Prevalence of Alzheimer's Disease

Kaynara Trevisan  1 , Renata Cristina-Pereira  1 , Danyelle Silva-Amaral  1 , Tales Alexandre Aversi-Ferreira  1   2
Affiliations
Review

Theories of Aging and the Prevalence of Alzheimer's Disease

Kaynara Trevisan et al. Biomed Res Int. .

Abstract

Objective: Aging and AD are associated in some way, then it is reasonable to ask whether or not it is possible to age without AD inexorably appearing at any moment, depending on the period of life. Therefore, the goal of this review is to verify, in light of some aging theories, the prevalence of AD.

Methods: For the purpose of this manuscript, the indexers Alzheimer, aging, Alzheimer, and aging were considered; theories of aging were researched. The research was conducted using PubMed, Medline, Scopus, Elsevier, and Google Scholar.

Results: The most common subjects in the papers analyzed for this manuscript were aging and Alzheimer's disease. The association between Alzheimer and theories of aging seems inconclusive.

Conclusions: Accordingly, the general idea is that AD is associated with aging in such a way that almost all people will present this disease; however, it is plausible to consider that the increase in life expectancy will generate a high prevalence of AD. In a general sense, it seems that the theories of aging explain the origin of AD under superlative and catastrophic considerations and use more biomolecular data than social or behavioral data as the bases of analysis, which may be the problem.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Number of papers for each subject studied for this manuscript. (1) Aging; (2) Alzheimer's disease; (3) Alzheimer's and aging; (4) other.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Korolev I. O., Hoisington L. A., Berger K. L., Bozoki A. C. Subtypes of mild cognitive impairment differentiated based on limbic white matter integrity and cortical glucose metabolism: A pilot study using DTI and FDG-PET. Alzheimer's & Dementia. 2010;6(4):p. S10. doi: 10.1016/j.jalz.2010.05.027. - DOI
    1. Duboisa B., Padovanib A., Scheltensc P., Rossid A., Agnello G. D. Timely diagnosis for alzheimer's disease: A literature review on benefits and challenges. Journal of Alzheimer's Disease. 2016;49(3):617–631. doi: 10.3233/JAD-150692. - DOI - PMC - PubMed
    1. Neres A. C., Rodrigues H. G., Aversi-Ferreira T. A. Alzheimer and parkinson diseases associate to aging. Bioscience Journal. 2009;25(2):139–151.
    1. Xu Z., Xiao N., Chen Y., et al. Deletion of aquaporin-4 in APP/PS1 mice exacerbates brain Aβ accumulation and memory deficits. Molecular Neurodegeneration. 2015;10(1, article no. 56):58–74. doi: 10.1186/s13024-015-0056-1. - DOI - PMC - PubMed
    1. O'Bryant S. E., Mielke M. M., Rissman R. A., et al. Blood-based biomarkers in Alzheimer disease: Current state of the science and a novel collaborative paradigm for advancing from discovery to clinic. Alzheimer’s & Dementia. 2017;13(1):45–58. doi: 10.1016/j.jalz.2016.09.014. - DOI - PMC - PubMed